时间：2023-12-05 03:33:03 来源：网络整理 编辑：부모와 아이
Daewoong Pharmaceutical said Tuesday that its botulinum toxin product, Nabota, posted 113.3 billion
Daewoong Pharmaceutical said Tuesday that its botulinum toxin product, Nabota, posted 113.3 billion won ($85.3 million) in sales as of the third quarter this year.
Overseas sales made up 93.5 billion won or 83 percent of the total, the company added.
Nabota's overseas sales have continued growing in recent years, an outcome of Daewoon's global push. The portion reached 61 percent in 2021 and then surged to 77 percent last year.
US sales, in particular, reached 44.5 billion won, making up more than 50 percent of global sales.
“Nabota’s share in the US botulinum toxin market has surged over the last two years. We expect to further boost our share in the future," a Daewoong official said.
Nabota, sold as Jeuveau in the US, made its US debut in 2020 through local partner Evolus’ botulinum toxin treatment program. Nabota currently has around an 11 percent share in the US botulinum toxin market, according to the company.
“Nabota was able to take the lead among Korea’s botulinum toxin products as Daewoong set its plans ahead for its launch in the US and received approval from the US Food and Drug Administration fast,” said Park Seong-soo, vice president of Daewoong Pharmaceutical.
In South Korea, a total of 11 botulinum toxin products have received approval from the government so far, and three additional products are under review.
Daewoong said the company will speed up Nabota launches in European countries, including Germany, Italy and Austria.
The company added it would also make a foray into the Malaysian market soon. In August, Daewoong received sales approval from the National Pharmaceutical Regulatory Agency in Malaysia.
Fugitive caught 3 days after escape from hospital2023-12-05 03:19
Enhypen's new album to be led by 'Sweet Venom'2023-12-05 03:02
尹대통령 “군장병 확고한 국가관·대적관 안보대세 가져야”2023-12-05 02:56
홍준표 "엑스포 박빙 보고…尹 파리 출장가게 한 참모들 징계해야"2023-12-05 02:38
CJ debuts K2023-12-05 01:23
CJ debuts K2023-12-05 01:20
Celltrion's Zymfentra to make US debut in February2023-12-05 01:10
Former divas return as Golden Girls2023-12-05 03:12
Pianist Chung Kyu2023-12-05 02:30
Zerobaseone reaches 'Melting Point' with 2nd EP2023-12-05 01:55
Bomb threat causes midnight fuss at Yonsei university2023-12-05 01:43
Visa applications open for additional 12,900 foreign workers2023-12-05 01:36
Insurance firms' net income jumps over 47% on2023-12-05 01:15